Application of assay of platelet monoamine oxidase type-B (MAO-B) activity to the discrimination of selegiline use from methamphetamine abuse

Journal of Health Science

Volumn 49, Issue 3, 2003, Pages 189-194

  Katagi, Munehiro ^a   Tsutsumi, Hiroe ^a   Tatsuno, Michiaki ^a   Kamata, Tohru ^a   Nishioka, Hiroshi ^a   Miki, Akihiro ^a   Nakajima, Kunio ^a   Tsuchihashi, Hitoshi ^a  

^a OSAKA PREFECTURE UNIVERSITY   (Japan)

Author keywords

Methamphetamine; Platelet monoamine oxidase type B; Selegiline

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOLOGICAL MARKER; DRUG METABOLITE; METHAMPHETAMINE; NORSELEGILINE; SELEGILINE; SELEGILINE N OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEAMINATION; DRUG ABUSE; DRUG DISCRIMINATION; DRUG METABOLISM; DRUG POTENCY; DRUG USE; ENANTIOMER; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SUBSTRATE; ENZYME SYNTHESIS; FLUOROMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEASUREMENT; PRECURSOR; THROMBOCYTE; TOXICOKINETICS;

EID: 24744449948     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.49.189     Document Type: Article

References (17)

1. Knoll, J. (1978) The possible mechanisms of action of (-)deprenyl in Parkinson's disease. J. Neural Transm., 43, 177-198.
2. Heinonen, E. H. and Lammintausta, R. (1991) A review of the pharmacology of selegiline. Acta Neurol. Scand., 84 (Suppl.), 44-59.
3. Szatmari, I. and Toth, K. (1992) Pharmacokinetics and metabolism of selegiline. Acta Pharm. Hung, 62, 243-248.
4. Katagi, M., Tatsuno, M., Tsutsumi, H., Miki, A., Kamata, T., Nishioka, H., Nakajima, K., Nishikawa, M. and Tsuchihashi, H. (2002) Urinary excretion of selegiline N-oxide, a new indicator for selegiline administration in man. Xenobiotica, 32, 823-831.
5. Maurer, H. H. and Kraemer, T. (1992) Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine. Arch. Toxicol., 66, 675-678.
6. Hasegawa, M., Matsubara, K., Fukushima, S., Maseda, C., Uezono, T. and Kimura, K. (2000) Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy. Forensic Sci. Int., 101, 95-106.
7. Katagi, M., Nishioka, H., Nakajima, K., Tsuchihashi, H., Fujima, H., Wada, H., Nakamura, K. and Makino, K. (1996) Direct high-performance liquid chromatographic and high-performance liquid chromatographic-thermospray-mass spectrometric determination of enantiomers of methamphetamine and its main metabolites amphetamine and p-hydroxymethamphetamine in human urine. J. Chromatogr. B, 676, 35-43.
8. Nagai, T., Matsushima, K., Nagai, T., Yanagisawa, Y., Fujita, A., Kurosu, A. and Tokudome, S. (2000) Interpretation and enantiomer analysis of methamphetamine abusers' urine and illegally brewed methamphetamine crystals. J. Anal. Toxicol., 24, 140-145.
9. Katagi, M., Miki, A., Tatsuno, M., Nakajima, K. and Tsuchihashi, H. (2001) Enantiomeric screening of methamphetamine in urine by EMIT®. Jpn. J. Forensic Toxicol., 19, 206-217.
10. Katagi, M., Tatsuno, M., Miki, A., Nishikawa, M., Nakajima, K. and Tsuchihashi, H. (2001) Simultaneous determination of selegiline-N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B, 759, 125-133.
11. Heinonen, E. H., Anttila, M. I., Nyman, L. M., Pyykko, K. A., Vuorinen, J. A. and Lammintausta, R. A. S. (1997) Inhibition of platelet monoamine oxidase type B by selegiline. J. Clin. Pharmacol., 37, 597-601.
12. Shimazu, S., Nakao, C., Tanida, N., Sakae, M., Morimoto, K. and Ohde, H. (1998) Effects of selegiline hydrochloride on the monoaminergic system of rat brain. Jpn. Pharmacol. Ther., 26, 1675-1682.
13. Yang, H. Y. T. and Neff, N. H. (1974) The monoamine oxidases of brain; Selective inhibition with drugs and the concequences for metabolism of the biogenic amines. J. Pharmacol. Exp. Ther., 189, 733-740.
14. Da Parada, M., Cesura, A. M., Launay, J. M. and Richards, J. G. (1988) Platelets as a model for neurons? Experimentia, 44, 115-126.
15. Ogamo, A., Ueda, M. and Fukumoto, M. (2001) N-Demethylation of methamphetamine and selegiline. Jpn. J. Forensic Toxicol., 19, 140-141.
16. Buzas, A. and Dufour, C. (1950) Sur la preparation de la b-(para-oxy-phenyl)-isopropyl methylamine. Bull. Soc. Chim. Fr., 139-140.
17. Krajl, M. (1965) A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacal., 14, 1684-1686.